Glass House Brands (GLAS) Change in Inventory (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Change in Inventory of -$5.3 million for Q1 2026, down 271.33% year-over-year from $3.1 million in Q1 2025, and down 131.05% quarter-over-quarter from $17.1 million in Q4 2025.
Glass House Brands (GLAS) Change in Inventory (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Change in Inventory for 7 consecutive years, with -$5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 271.33% year-over-year to -$5.3 million; the TTM figure through Mar 2026 stood at $8.1 million (up 27.42% YoY), while the FY2025 annual figure was $12.0 million, up 121.27% from the prior year.
- Change in Inventory slipped to -$5.3 million in Q1 2026 per GLAS's latest filing, from $17.1 million in the prior quarter.
- Across five years, Change in Inventory topped out at $17.1 million in Q4 2025 and bottomed at -$5.3 million in Q1 2026.
- Historically, Change in Inventory has averaged $1.1 million across 5 years, with a median of $293000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Inventory slumped 331.66% — and 2024, when it surged 828.91%.
- Glass House Brands' Change in Inventory stood at $922000.0 in 2022, then tumbled by 298.49% to -$1.8 million in 2023, then soared by 828.91% to $13.3 million in 2024, then advanced by 28.18% to $17.1 million in 2025, then plunged by 131.05% to -$5.3 million in 2026.
- Business Quant data shows GLAS's Change in Inventory at -$5.3 million in Q1 2026, $17.1 million in Q4 2025, and $293000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 831.09 Mn | 812.54 Mn | 15.77 Mn | -4.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.31 Mn |
| Mar 31, 2026 | -5.31 Mn |
| Dec 31, 2025 | 17.10 Mn |
| Dec 31, 2025 | 17.10 Mn |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | -3.99 Mn |
| Jun 30, 2025 | -3.99 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Dec 31, 2023 | -1.83 Mn |